We’re advancing ESG initiatives that contribute to our sustainable growth, so that we can create a positive impact for generations to come.
Our leaders are stewards of our environmental, social and governance mission, and our people are committed to ensuring our research, innovations and collaborations put impact for people, communities and our world first.
We discover and deliver innovative medicines.
We unlock the full potential of our diverse and talented teams and partners to deliver today and into the future.
We innovate with integrity and intention to advance long-term patient health and business resiliency.
We periodically conduct materiality assessments to inform which environmental, social & governance (ESG) issues are most relevant to our business and our stakeholders. Reviewed and approved by executive leadership, we identified our material ESG topics by gathering and analyzing insights and feedback from a variety of internal and external stakeholders, including senior cross-functional leadership, employees, investors, community partners, patients, regulators and more.
We are committed to discovering and delivering innovative medicines aimed at addressing serious health conditions and improving the lives of patients.
We are committed to delivering safe and effective products and medicines through robust quality systems.
We are dedicated to making a positive impact on health outcomes for patients worldwide
We act with integrity in everything we do.
We’re guided by openness and transparency in our relationships with health care providers (HCPs), and health care organizations (HCOs). The objective of the Voluntary Disclosure of Payments initiative is to increase transparency about our operations in Canada and in doing so, increase trust with stakeholders within our healthcare system. Bringing greater transparency to these valuable and well-regulated relationships will contribute to enhancing trust and value for patients, as well as our healthcare system.
You will be leaving your country’s AbbVie site and will be redirected to another country’s website. The AbbVie’s web site to where you will be redirected is exclusively designed for residents of particularly one or various countries, as announced in such web site. As a result, the website where you will be directed may contain pharmaceutical products information or other information that is not approved in other countries, regions or even in your country or territory of reference. If you live in a country other than those to which the site is directed, please contact your local AbbVie affiliate for the correct information on the products of your country of residence.